Format

Send to

Choose Destination
Int J Cardiol. 2015 Apr 1;184:568-9. doi: 10.1016/j.ijcard.2015.02.112. Epub 2015 Mar 5.

Adaptive licensing - A way forward in the approval process of new therapeutic agents in Europe.

Author information

1
Centro di Ricerca Clinica e Sperimentale, IRCCS Sn Raffaele Roma, Italy. Electronic address: grosano@sgul.ac.uk.
2
Innovative Clinical Trials, University of Gottinghen, Germany.
3
Federazione Italiana Medici di Famiglia, Rome, Italy.
4
Monash-Warwick University Alliance, United Kingdom.

KEYWORDS:

Cardiovascular; Clinical trial; Drug therapy; European Medicines Agency; Heart failure; Innovative therapies; Pharmacovigilance; Regulatory science

PMID:
25767018
DOI:
10.1016/j.ijcard.2015.02.112
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center